A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)

NCT05582993 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Von Willebrand Disease (VWD)

Interventions

BIOLOGICAL: Vonicog Alfa
BIOLOGICAL: ADVATE

Sponsor

Takeda